유럽의 신속 검사 키트 시장 예측(-2030년) : 지역별 분석 - 유형, 제품, 기술, 용도, 최종사용자별

The Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030; it is estimated to record a CAGR of 5.0% from 2022 to 2030.

Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market

Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.

In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women's and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.

In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.

In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.

In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.

In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.

Europe Rapid Test Kit Market Overview

The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.

Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Europe Rapid Test Kit Market Segmentation

The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Rapid Test Kits Market - Key Industry Dynamics

• 4.1 Market Drivers
  • 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
  • 4.1.2 Strategic Initiatives by Manufacturers
• 4.2 Market Restraints
  • 4.2.1 Uncertainties Related to Accuracy of Results
• 4.3 Market Opportunities
  • 4.3.1 Increasing Preference for PCR Techniques
• 4.4 Future Trends
  • 4.4.1 Innovations in Rapid Antigen Tests
• 4.5 Impact Analysis

5. Rapid Test Kits Market - Europe Market Analysis

• 5.1 Overview
• 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Europe Rapid Test Kits Market Analysis - by Type

• 6.1 Overview
• 6.2 Rapid Antigen Testing
  • 6.2.1 Overview
  • 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 6.3 Rapid Antibody Testing
  • 6.3.1 Overview
  • 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Others
  • 6.4.1 Overview
  • 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Rapid Test Kits Market Analysis - by Product

• 7.1 Overview
• 7.2 Over-the-Counter Rapid Testing Kit
  • 7.2.1 Overview
  • 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 7.3 Professional Rapid Testing Kit
  • 7.3.1 Overview
  • 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Rapid Test Kits Market Analysis - by Technology

• 8.1 Overview
• 8.2 Lateral Flow Assay
  • 8.2.1 Overview
  • 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 8.3 Solid Phase
  • 8.3.1 Overview
  • 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Agglutination
  • 8.4.1 Overview
  • 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 8.5 Immunospot Assay
  • 8.5.1 Overview
  • 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 8.6 Cellular-Component Based
  • 8.6.1 Overview
  • 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Rapid Test Kits Market Analysis - by Application

• 9.1 Overview
• 9.2 Blood Glucose Testing
  • 9.2.1 Overview
  • 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 9.3 Infectious Disease Testing
  • 9.3.1 Overview
  • 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Cardiometabolic Testing
  • 9.4.1 Overview
  • 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Pregnancy and Fertility
  • 9.5.1 Overview
  • 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Rapid Test Kits Market Analysis - by End User

• 10.1 Overview
• 10.2 Hospital and Clinics
  • 10.2.1 Overview
  • 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 10.3 Diagnostic Centers
  • 10.3.1 Overview
  • 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Home-Care
  • 10.4.1 Overview
  • 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
• 10.5 Others
  • 10.5.1 Overview
  • 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Rapid Test Kits Market - Country Analysis

• 11.1 Europe
  • 11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
    • 11.1.1.1 Germany
      • 11.1.1.1.1 Overview
    • 11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
    • 11.1.1.3 United Kingdom
      • 11.1.1.3.1 Overview
    • 11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
    • 11.1.1.5 France
      • 11.1.1.5.1 Overview
    • 11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
    • 11.1.1.7 Italy
      • 11.1.1.7.1 Overview
    • 11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
    • 11.1.1.9 Spain
      • 11.1.1.9.1 Overview
    • 11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
    • 11.1.1.11 Rest of Europe
      • 11.1.1.11.1 Overview
    • 11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
      • 11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
      • 11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
      • 11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
      • 11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
      • 11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in the Rapid Test Kit Market
• 12.3 Inorganic Growth Strategies
  • 12.3.1 Overview
• 12.4 Organic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Becton Dickinson and Co
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 ARKRAY Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 Sysmex Partec GmbH
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Fujirebio Europe NV
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 bioMerieux SA
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Cepheid
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 Meril Life Sciences Pvt Ltd
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 QIAGEN NV
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 OraSure Technologies Inc
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
• 13.11 Guangzhou Wondfo Biotech Co Ltd
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
• 13.12 Denka Co Ltd
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments
• 13.13 Abbott Laboratories
  • 13.13.1 Key Facts
  • 13.13.2 Business Description
  • 13.13.3 Products and Services
  • 13.13.4 Financial Overview
  • 13.13.5 SWOT Analysis
  • 13.13.6 Key Developments
• 13.14 Trinity Biotech Plc
  • 13.14.1 Key Facts
  • 13.14.2 Business Description
  • 13.14.3 Products and Services
  • 13.14.4 Financial Overview
  • 13.14.5 SWOT Analysis
  • 13.14.6 Key Developments
• 13.15 Bio-Rad Laboratories Inc
  • 13.15.1 Key Facts
  • 13.15.2 Business Description
  • 13.15.3 Products and Services
  • 13.15.4 Financial Overview
  • 13.15.5 SWOT Analysis
  • 13.15.6 Key Developments
• 13.16 Hologic Inc
  • 13.16.1 Key Facts
  • 13.16.2 Business Description
  • 13.16.3 Products and Services
  • 13.16.4 Financial Overview
  • 13.16.5 SWOT Analysis
  • 13.16.6 Key Developments
• 13.17 DiaSorin SpA
  • 13.17.1 Key Facts
  • 13.17.2 Business Description
  • 13.17.3 Products and Services
  • 13.17.4 Financial Overview
  • 13.17.5 SWOT Analysis
  • 13.17.6 Key Developments
• 13.18 Premier Medical Corp Pvt Ltd
  • 13.18.1 Key Facts
  • 13.18.2 Business Description
  • 13.18.3 Products and Services
  • 13.18.4 Financial Overview
  • 13.18.5 SWOT Analysis
  • 13.18.6 Key Developments
• 13.19 Beckman Coulter Inc
  • 13.19.1 Key Facts
  • 13.19.2 Business Description
  • 13.19.3 Products and Services
  • 13.19.4 Financial Overview
  • 13.19.5 SWOT Analysis
  • 13.19.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners